| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $65.9M | — | +4.1% |
| Cost of Revenue | $17.4M | — | +7.1% |
| Gross Profit | $48.5M | — | +3.0% |
| R&D Expense | $9.1M | — | +14.5% |
| SG&A Expense | $11.0M | — | +14.8% |
| Operating Income | $14.8M | — | -13.8% |
| Pre-tax Income | $14.4M | — | -19.3% |
| Income Tax | $2.8M | — | -15.3% |
| Net Income | $11.6M | — | -20.3% |
| EPS (Basic) | $0.31 | — | -18.4% |
| EPS (Diluted) | $0.30 | — | -18.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $49.8M | -29.4% | -52.7% |
| Accounts Receivable | $33.2M | -40.6% | +12.3% |
| Inventory | $9.1M | -12.7% | -17.1% |
| Current Assets | $122.9M | -28.6% | -28.0% |
| Total Assets | $383.1M | -3.7% | +14.8% |
| Current Liabilities | $98.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.2M | — | -4.1% |
| Capital Expenditures | $3.1M | — | +91.9% |
| Investing Cash Flow | -$37.8M | — | -2195.1% |
| Financing Cash Flow | -$11.4M | — | -92.3% |
| Free Cash Flow | $25.1M | — | -9.7% |
| +12.6% |
| Total Liabilities | $111.1M | -11.7% | +8.2% |
| Stockholders' Equity | $272.0M | +0.1% | +17.7% |